Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. (Q54012115)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. |
scientific article |
Statements
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. (English)
1 reference
Koukourakis MI
1 reference
Giatromanolaki A
1 reference
Kakolyris S
1 reference
Sivridis E
1 reference
Georgoulias V
1 reference
Funtzilas G
1 reference
Hickson ID
1 reference
Gatter KC
1 reference
Harris AL
1 reference
1 May 2001
1 reference
50
1 reference
1
1 reference
27-36
1 reference
Identifiers
1 reference